Neurological

Exservan now available for amyotrophic lateral sclerosis

Subjects ” Neuromuscular Diseases

Exservan ™ (riluzole oral film) is now available for the treatment of amyotrophic lateral sclerosis (ALS).

The approval was based on pharmacokinetic studies demonstrating the bioequivalence of oral Exservan Film with oral riluzole tablets. The mechanism by which riluzole exerts its therapeutic effects in ALS patients is unknown, but clinical studies have shown that it modulates glutamate neurotransmission by inhibiting both glutamate release and postsynaptic glutamate receptor signaling.

In terms of safety, the most commonly reported side effects during treatment are oral hypoesthesia, asthenia, nausea, decreased lung function, high blood pressure, and abdominal pain. The use of Exservan is not recommended in patients with baseline increases in serum aminotransferases more than 5 times the upper limit of normal; Serum aminotransferases should be measured before and during treatment.

Continue reading

Exservan is available through a single specialty pharmacy, PANTHERx Rare Pharmacy. Each oral film contains 50 mg riluzole and is supplied as a single sachet or in a 60-pack. The mouth film is applied to the tongue, where it adheres and dissolves. Treatment should take place at least 1 hour before or 2 hours after a meal.

“Many people with ALS have or will have difficulty swallowing some medications. I’ve even heard of some patients crushing pills to take their medication, ”said Gary L. Pattee, MD, a neurologist and ALS specialist from Lincoln, Nebraska. “Alternative formulations of riluzole can play an important role in the treatment plan for people with ALS, including those who have difficulty swallowing some drugs.”

References

  1. Mitsubishi Tanabe Pharma America announces that Exservan ™ (riluzole) is now available in the US for the treatment of ALS. [press release]. Jersey City, NJ: Mitsubishi Tanabe Pharma America, Inc .; 06/30/2021.
  2. Exservan ™ [package insert]. Jersey City, NJ: Mitsubishi Tanabe Pharma America, Inc .; 2021.

This article originally appeared on MPR

Subjects:

Amyotrophic lateral sclerosis treatments for neuromuscular diseases

Would you like to read more?

Please log in or register first to view this content.

Login Register

to open

Next post in Neuromuscular Disorders

Shut down


More information on Exservan now available for amyotrophic lateral sclerosis

Loading…


More information on Exservan now available for amyotrophic lateral sclerosis

Loading…


More information on Exservan now available for amyotrophic lateral sclerosis

Loading…


More information on Exservan now available for amyotrophic lateral sclerosis

Loading…

Would you like to see more content from Neurology Advisor?

Register now for free to access unlimited clinical news with personalized daily tips for you, Full-length features, case studies, conference coverage, and more.

{{login-button}} {{register-button}}

Would you like to read more?

Please log in or register first to view this content.

Login Register

Related Articles